MA43980A - Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires - Google Patents

Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires

Info

Publication number
MA43980A
MA43980A MA043980A MA43980A MA43980A MA 43980 A MA43980 A MA 43980A MA 043980 A MA043980 A MA 043980A MA 43980 A MA43980 A MA 43980A MA 43980 A MA43980 A MA 43980A
Authority
MA
Morocco
Prior art keywords
prognosis
diagnosis
events
methods
cardiovascular diseases
Prior art date
Application number
MA043980A
Other languages
English (en)
Inventor
James Louis Januzzi Jr
Craig Agamemnon Magaret
Rhonda Fay Rhyne
John Edward Strobeck
Original Assignee
Prevencio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevencio Inc filed Critical Prevencio Inc
Publication of MA43980A publication Critical patent/MA43980A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Optics & Photonics (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
MA043980A 2016-02-01 2017-02-01 Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires MA43980A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662289513P 2016-02-01 2016-02-01
US201662378535P 2016-08-23 2016-08-23

Publications (1)

Publication Number Publication Date
MA43980A true MA43980A (fr) 2018-12-12

Family

ID=59500904

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043980A MA43980A (fr) 2016-02-01 2017-02-01 Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires

Country Status (13)

Country Link
US (4) US10983135B2 (fr)
EP (2) EP4574024A3 (fr)
JP (4) JP7134870B2 (fr)
KR (1) KR20180101595A (fr)
CN (2) CN108700596A (fr)
AU (1) AU2017214469A1 (fr)
BR (1) BR112018015698A2 (fr)
CA (1) CA3012192A1 (fr)
MA (1) MA43980A (fr)
MX (1) MX2018009304A (fr)
RU (1) RU2018130866A (fr)
SG (1) SG11201805906WA (fr)
WO (1) WO2017136464A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10983135B2 (en) 2016-02-01 2021-04-20 Prevencio, Inc. Diagnostic and prognostic methods for cardiovascular diseases and events
WO2019055609A1 (fr) * 2017-09-14 2019-03-21 University Of Alabama At Birmingham Biomarqueurs et méthodes d'évaluation de risque d'infarctus du myocarde et d'infection grave chez des patients atteints de polyarthrite rhumatoïde
JP7372251B2 (ja) * 2017-11-02 2023-10-31 プリベンシオ，インコーポレイテッド 末梢動脈疾患、大動脈弁狭窄症についての診断および予後の方法、ならびにアウトカム
US11009452B2 (en) * 2018-01-26 2021-05-18 Viavi Solutions Inc. Reduced false positive identification for spectroscopic quantification
US11656174B2 (en) 2018-01-26 2023-05-23 Viavi Solutions Inc. Outlier detection for spectroscopic classification
EP3928098B1 (fr) * 2019-02-20 2025-01-08 Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol In vitro procédé pour prédire le risque de mortalité chez des patients atteints d'un choc cardiogénique
CN110232975A (zh) * 2019-05-20 2019-09-13 郑州大学第一附属医院 一种对糖尿病肾病患者3年内进入到肾脏替代治疗风险预测的方法
CN110491512A (zh) * 2019-08-08 2019-11-22 郑州大学第一附属医院 一种对肾活检确诊糖尿病肾病患者3年内进入到终末期肾脏病风险预测的方法
CN110596399B (zh) * 2019-08-29 2022-07-22 首都医科大学附属北京安贞医院 检测血管生成素样蛋白8含量的物质的应用
CN110970131B (zh) * 2019-10-24 2024-01-26 中国医科大学附属盛京医院 一种基于免疫球蛋白定量检测的肾小球疾病分类分型模型及其应用
RU2726314C1 (ru) * 2019-11-15 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ раннего прогнозирования риска острого повреждения почек у пациентов с ишемической болезнью сердца после реваскуляризации миокарда методом аортокоронарного шунтирования
RU2760445C1 (ru) * 2020-11-13 2021-11-25 Виталий Юрьевич Мишланов Способ диагностики патологических состояний человека
JP7717152B2 (ja) * 2021-03-23 2025-08-01 テルモ株式会社 情報処理装置、情報処理方法およびプログラム
CN113342963B (zh) * 2021-04-29 2022-03-04 山东大学 一种基于迁移学习的服务推荐方法及系统
RU2770550C1 (ru) * 2021-05-31 2022-04-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования сердечно-сосудистого риска с помощью определения уровня эстрогенов
WO2023192004A2 (fr) * 2022-03-30 2023-10-05 Inflammatix, Inc. Procédés de diagnostic d'infarctus du myocarde
CN115185936B (zh) 2022-07-12 2023-02-03 曜立科技(北京)有限公司 一种基于大数据的医疗临床数据质量分析系统
CN114974576A (zh) * 2022-07-12 2022-08-30 曜立科技(北京)有限公司 一种基于元数据的心脑血管数疾病诊断管理系统

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US20080202927A1 (en) 2000-11-03 2008-08-28 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
US20030134433A1 (en) 2002-01-16 2003-07-17 Nanomix, Inc. Electronic sensing of chemical and biological agents using functionalized nanostructures
US20060228723A1 (en) 2002-01-16 2006-10-12 Keith Bradley System and method for electronic sensing of biomolecules
US9234867B2 (en) 2003-05-16 2016-01-12 Nanomix, Inc. Electrochemical nanosensors for biomolecule detection
US8685711B2 (en) 2004-09-28 2014-04-01 Singulex, Inc. Methods and compositions for highly sensitive detection of molecules
WO2006089226A1 (fr) * 2005-02-17 2006-08-24 University Of Florida Research Foundation, Inc. Pharmacogénétique de betabloquant dans l'insuffisance cardiaque
CN101495862A (zh) * 2005-06-24 2009-07-29 利兰·斯坦福青年大学托管委员会 诊断和监测动脉粥样硬化性心血管疾病的方法和组合物
US8093017B2 (en) * 2005-12-07 2012-01-10 Siemens Heathcare Diagnostics Inc. Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
WO2007123708A2 (fr) * 2006-03-31 2007-11-01 Epitome Biosystems, Inc. Analyse de configuration de modification post-translationnelle
CA2659082A1 (fr) 2006-06-07 2007-12-21 Tethys Bioscience, Inc. Marqueurs associes a des evenements arterio-vasculaires et procedes d'utilisation de ces marqueurs
WO2008045799A2 (fr) 2006-10-06 2008-04-17 Nanomix, Inc. Nanodétecteurs électrochimiques pour la détection de biomolécules
PL2084543T3 (pl) 2006-10-26 2018-04-30 B.R.A.H.M.S Gmbh Stratyfikacja ryzyka ostrego zespołu wieńcowego za pomocą fragmentów/ częściowych peptydów prowazopresyny, a zwłaszcza kopeptyny lub neurofizyny II
WO2008131039A2 (fr) 2007-04-16 2008-10-30 Board Of Regents, The University Of Texas System Cardibioindice/cardibioscore et utilité d'un protéome salivaire dans des diagnostics cardiovasculaires
US20100119600A1 (en) 2007-06-01 2010-05-13 Joar Opheim Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
WO2009040133A1 (fr) * 2007-09-26 2009-04-02 Universitätsklinikum Heidelberg Ostéopontine en tant que nouveau biomarqueur de pronostic de l'insuffisance cardiaque
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
JP5775868B2 (ja) 2009-06-04 2015-09-09 コーニンクレッカ フィリップス エヌ ヴェ 不眠症のための行動療法を提供するシステム及びその制御方法
WO2010144358A1 (fr) 2009-06-08 2010-12-16 Singulex, Inc. Groupes de biomarqueurs très sensibles
WO2011022628A1 (fr) 2009-08-20 2011-02-24 The Board Of Regents Of The University Of Texas System Procédés et compositions pour le diagnostic d’un infarctus du myocarde aigu (ami)
AU2010328019A1 (en) * 2009-12-09 2012-06-28 Aviir, Inc. Biomarker assay for diagnosis and classification of cardiovascular disease
KR101256928B1 (ko) * 2010-01-20 2013-04-19 주식회사디엔에이링크 비만 또는 당뇨에 관련된 단일염기다형성 및 그의 용도
US20140045714A1 (en) * 2010-10-27 2014-02-13 Robert Gerszten Novel Biomarkers For Cardiovascular Injury
WO2012072595A1 (fr) * 2010-11-30 2012-06-07 Universiteit Gent Variant du facteur plaquettaire 4 pour le pronostic de l'issue cardiovasculaire chez des patients atteints d'une maladie cardiaque
WO2012120387A1 (fr) 2011-03-09 2012-09-13 Abionic Sa Quantification rapide de biomolécules dans un biocapteur nanofluidique sélectivement fonctionnalisé et procédé associé
WO2012145037A1 (fr) 2011-04-19 2012-10-26 Scott & White Healthcare Nouveaux isoformes de l'apoc-i et leur utilisation en tant que biomarqueurs et facteurs de risque de l'athérosclérose
US20140011811A1 (en) * 2011-10-06 2014-01-09 The United States Government As Represented By The Department Of Veterans Affairs Myosin binding protein-c for use in methods relating to diastolic heart failure
WO2014078615A1 (fr) * 2012-11-16 2014-05-22 Siemens Healthcare Diagnostics Inc. Procédé d'identification d'un traitement optimal d'une coronaropathie
EP3019873A1 (fr) 2013-07-12 2016-05-18 Emory University Dosage de diagnostic pour la prédiction d'un risque cardiovasculaire
US9989526B2 (en) 2013-07-17 2018-06-05 Abionic Sa Method and device for bioassays
US20150160229A1 (en) * 2013-12-06 2015-06-11 Thomas D. Schaal Methods for detection of heart failure
US10509044B2 (en) * 2014-05-08 2019-12-17 University Of Maryland, Baltimore Methods for assessing differential risk for developing heart failure
CN106573240B (zh) 2014-07-03 2020-05-01 阿比奥尼克公司 用于诸如全血的流体试样的快速分子定量的胶囊
US10983135B2 (en) 2016-02-01 2021-04-20 Prevencio, Inc. Diagnostic and prognostic methods for cardiovascular diseases and events
JP7310591B2 (ja) 2019-12-19 2023-07-19 株式会社オートネットワーク技術研究所 駆動装置

Also Published As

Publication number Publication date
JP7403498B2 (ja) 2023-12-22
CA3012192A1 (fr) 2017-08-10
US10983135B2 (en) 2021-04-20
EP3411720C0 (fr) 2025-04-16
EP3411720A4 (fr) 2019-08-14
US11977083B2 (en) 2024-05-07
BR112018015698A2 (pt) 2018-12-26
EP4574024A2 (fr) 2025-06-25
RU2018130866A (ru) 2020-03-04
JP2025029196A (ja) 2025-03-05
CN114441773A (zh) 2022-05-06
EP3411720B1 (fr) 2025-04-16
MX2018009304A (es) 2019-01-10
AU2017214469A1 (en) 2018-07-26
US12146888B2 (en) 2024-11-19
WO2017136464A1 (fr) 2017-08-10
SG11201805906WA (en) 2018-08-30
EP4574024A3 (fr) 2025-10-08
JP2022171936A (ja) 2022-11-11
JP2019507354A (ja) 2019-03-14
EP3411720A1 (fr) 2018-12-12
JP7134870B2 (ja) 2022-09-12
JP2021128177A (ja) 2021-09-02
CN108700596A (zh) 2018-10-23
US20190369120A1 (en) 2019-12-05
US20210072260A1 (en) 2021-03-11
US20230341418A1 (en) 2023-10-26
US20250060374A1 (en) 2025-02-20
KR20180101595A (ko) 2018-09-12

Similar Documents

Publication Publication Date Title
EP3411720A4 (fr) Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires
EP3411505A4 (fr) Détection et diagnostic d'évolution d'un cancer
EP3337465A4 (fr) Compositions et méthodes d'utilisation en association destinées au traitement et au diagnostic de maladies auto-immunes
EP3985126C0 (fr) Diagnostic non invasif de la stéatohépatite non alcoolique fibrotique
EP3454745A4 (fr) Personnalisation du diagnostic en termes de de santé et de maladie
EP3482201A4 (fr) Diagnostic précoce d'infections
EP3405574A4 (fr) Diagnostic et suivi de maladie à base de variant
IL257680A (en) Methods for diagnosing and evaluating non-alcoholic steatohepatitis
EP3655544A4 (fr) Méthode de diagnostic d'une dysbiose
EP3465218A4 (fr) Biomarqueurs liés aux maladies hépatiques et leurs méthodes d'utilisation
IL246917A0 (en) Biomarker and early diagnosis methods for Alzheimer's disease
EP3711680A4 (fr) Appareil de diagnostic de dysfonctionnement cognitif et programme de diagnostic de dysfonctionnement cognitif
EP3684954C0 (fr) Diagnostic non invasif de stéatoses hépatiques d'origine non alcoolique, stéatohépatite non alcoolique et/ou fibrose du foie
EP2968397A4 (fr) Diagnostic et traitement de la fibrose
EP3658139A4 (fr) Méthodes de traitement de maladies hépatiques
EP3362579A4 (fr) Méthodes de diagnostic de la tuberculose
EP3307329A4 (fr) Traitement et diagnostic du cancer
EP3490677A4 (fr) Marqueurs lipidiques, protéiques et métaboliques pour le diagnostic et le traitement du cancer de la prostate
IL269083A (en) Methods for preventing and treating heart disease
EP3542159A4 (fr) Quantification de sous-populations d'exosomes et diagnostic de troubles neurodégénératifs
EP3740590A4 (fr) Kits et méthodes de diagnostic du cancer du poumon
EP3631444A4 (fr) Biomarqueurs et stratégies de sélection de patients
EP3307913A4 (fr) Procédés de diagnostic et de traitement de l'autisme
EP3546943A4 (fr) Composition de diagnostic de maladies
EP3571310A4 (fr) Compositions et méthodes de diagnostic et de traitement des maladies peroxysomales